Astellas Pharma US | Changing Tomorrow | Home

Previous Pause Next

ASTELLAS IS COMMITTED TO COMMUNITY SUPPORT

ASTELLAS IS COMMITTED TO COMMUNITY SUPPORT

We are dedicated to supporting local and global communities as part of our COVID-19 response

Astellas a Top Ten Company for Working Mothers

Astellas ranks in Top 10 of Working Mother Magazine’s Best Companies List

We are committed to creating a diverse and inclusive workplace that enables success for all employees

C3 2020

WE CAN CHANGE CANCER CARE

Astellas Oncology opens annual C3 Prize call for entries to award best innovations in cancer care beyond medicine

revised newest covid

UPDATES AND INFORMATION

Find out how we're responding to our patients, our employees and our community

1

2

3

4

News

Latest

News / Media

Jul 22, 2020

Astellas is Awarded Grant from the U.S. National Institutes of Health (NIH) to Fund Early Clinical Studies of ASP8062 to Investigate Potential Novel Therapeutic Approach to Address the Opioid Crisis

News / Media

Jul 20, 2020

Astellas Named to FTSE4Good Index Series for Ninth Consecutive Year

News / Media

Jun 05, 2020

Astellas, City of Yokohama, and Yokohama City University Developed Science-Based Exercise Programs through Industry-Government-Academia Collaboration

News / Corporate

Sep 23, 2020

Astellas Establishes Global Patient Centricity Leadership Structure to Incorporate Patient Perspectives Across Research and Development Continuum

News / Therapeutic Area News

Sep 18, 2020

Astellas and Seattle Genetics Announce PADCEV® (enfortumab vedotin-ejfv) Significantly Improved Overall Survival in Phase 3 Trial in Previously Treated Locally Advanced or Metastatic Urothelial Cancer

News / Corporate Awards

Sep 15, 2020

Astellas Ranks Among Top Companies for Working Parents